Hearing Loss Clinical Trial
— VSBRWOfficial title:
Clinical Trial of the Vibrant Soundbridge as a Treatment for Conductive and Mixed Hearing Losses, Using Direct Round Window Cochlear Stimulation.
NCT number | NCT00748540 |
Other study ID # | G060227 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 2007 |
Est. completion date | March 2014 |
Verified date | September 2019 |
Source | Med-El Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this investigation is to collect feasibility data to assess the safety and efficacy of the Vibrant Soundbridge (VSB), a medical device designed to provide benefit in aided hearing thresholds, speech perception and sound quality to certain individuals with hearing loss with minimal changes in residual hearing. The VSB is currently indicated for adults with moderate-to-severe sensorineural hearing loss. Under the present investigation, adults with conductive and mixed hearing losses who are not successful users of traditional amplification will be assessed.
Status | Completed |
Enrollment | 50 |
Est. completion date | March 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adults, 18 years of age or older at time of implantation - English as the primary language - Appropriate motivation and expectation levels - Geographically and physically able to return to the investigational center for scheduled evaluations and follow-up appointments. - At least a 28-day unsuccessful hearing aid trial (within the past 24 months prior to enrolment). - Persons who after being informed that a different hearing aid than the one they currently have may provide improved hearing, still request an implant. - Ability to undergo general anesthesia - Audiological tests suggest either a conductive or mixed hearing loss. The non-implanted ear may fall outside these criteria; however, threshold levels may not be worse than severe sloping to profound. - Conductive Hearing Loss - Pure-tone bone-conduction threshold levels in the ear to be implanted shall fall at or within the levels stated below. There should be an air-bone gap of 15 dB HL or more at three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Pure-tone air-conduction levels should indicate the presence of at least a moderate hearing loss of at least 41 dB HL. Air conduction levels are not limited on the upper end. - Upper Limits of Bone Conduction Thresholds for Conductive Hearing Loss Frequency (kHz) 0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction upper limit (dBHL) <25 <25 <25 <25 <25 <25 - Mixed Hearing Loss - Pure-tone bone conduction threshold levels in the ear to be implanted shall fall at or within the levels stated below. There should be an air-bone gap of 15 dB HL or more at three or more of the frequencies 500, 1000, 1500, 2000, 3000, and 4000 Hz. Bone conduction thresholds at least three of the frequencies should be 26 dB or greater. Pure-tone air-conduction thresholds should be, on average, at least moderately impaired of 41 dB or greater. Air-conduction levels are not limited on the upper end. - Lower and Upper Limits of Bone Conduction Thresholds for Mixed Hearing Loss Frequency (kHz) 0.5 1.0 1.5 2.0 3.0 4.0 Bone Conduction lower limit (dBHL) 0 0 0 0 0 0 Bone Conduction upper limit (dBHL) 45 50 55 65 65 65 - Good potential for aided speech recognition as indicated by a pre-operative monosyllabic word score of > 30% in the ear to be implanted as measured under headphones at 40 dB SL or at MCL - Hearing aid trial with appropriately fitted hearing aids of at least 28 days duration within the past 24 months, unless the subject is unable to wear hearing aids for medical reasons - Most recent audiometric data, if available, judged to be of good test-retest reliability. Exclusion Criteria: - Hearing loss of purely sensorineural origin - Retrocochlear or central auditory disorders - Active middle ear infection - Tympanic membrane perforation, ears with previously reconstructed tympanic membranes may be included - Bone-conduction thresholds in the ear to be implanted that have demonstrated a recent fluctuation at two or more frequencies of 15 dB in either direction in the last 6 months, as demonstrated by serial audiograms. - History of post-adolescent, inner-ear disorders, such as vertigo or labyrinthitis - Chronic or non-revisable vestibular or balance disorders - Middle ear infections not responsive to medical treatment - Skin or scalp conditions that may preclude attachment of the Audio Processor or that may interfere with the use of the Audio Processor - Chronic pain in or around the head - Current or previous use of an active hearing implant in either ear. - Any known physical, psychological, or emotional disorder that may interfere with the completion of scheduled follow-up evaluations - Developmental delays or organic brain dysfunction |
Country | Name | City | State |
---|---|---|---|
United States | University of North Carolina Hospital | Chapel Hill | North Carolina |
United States | University of Texas Southwestern Medical Center | Dallas | Texas |
United States | Ear Institute of Chicago | Hinsdale | Illinois |
United States | Midwest Ear Institute | Kansas City | Missouri |
United States | University of Kansas Medical Center | Kansas City | Kansas |
United States | House Ear Institute | Los Angeles | California |
United States | University of Miami Ear Institute | Miami | Florida |
United States | Pittsburgh Ear Associates | Pittsburgh | Pennsylvania |
United States | Jennifer Maw, MD | San Jose | California |
United States | Silverstein Institute | Sarasota | Florida |
United States | Capitol Region Ear Institute | Slingerlands | New York |
Lead Sponsor | Collaborator |
---|---|
Med-El Corporation |
United States,
Colletti V, Soli SD, Carner M, Colletti L. Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol. 2006 Oct;45(10):600-8. — View Citation
Kiefer J, Arnold W, Staudenmaier R. Round window stimulation with an implantable hearing aid (Soundbridge) combined with autogenous reconstruction of the auricle - a new approach. ORL J Otorhinolaryngol Relat Spec. 2006;68(6):378-85. Epub 2006 Oct 26. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Speech Perception in Quiet (Monosyllables) in Patients Implanted With Vibrant Soundbridge | Percent correct on words in quiet at the preoperative interval compared to 6 month post operative interval. | 6 months post initial activation | |
Secondary | Functional Gain Compared to Preoperative Unaided Condition in Patients Implanted With Vibrant Soundbridge. | Auditory thresholds in the soundfield at the preoperative interval compared to the 6 month postoperative interval. | 6 months post initial activation | |
Secondary | Speech Perception in Noise (HINT Sentences) in Patients Implanted With Vibrant Soundbridge. | Signal to Noise Ratio for sentences at the preoperative interval compared to the 6 month interval. | 6 months post initial activation | |
Secondary | Residual Hearing in Patients Implanted With Vibrant Soundbridge | Unaided hearing thresholds measured at the 10 month interval compared to the preoperative interval in order to assess any changes | 10 months post initial activation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04696835 -
fNIRS in Pediatric Hearing Aids
|
N/A | |
Completed |
NCT03662256 -
Reducing Childhood Hearing Loss in Rural Alaska Through a Preschool Screening and Referral Process Using Mobile Health and Telemedicine
|
N/A | |
Completed |
NCT04602780 -
Evaluating the Revised WORQ in CI Users
|
||
Completed |
NCT03723161 -
Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
|
||
Completed |
NCT05086809 -
Investigation of an Updated Bone-anchored Sound Processor
|
N/A | |
Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
Completed |
NCT03428841 -
Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients
|
N/A | |
Completed |
NCT04559282 -
Home Test of New Sound Processor
|
N/A | |
Enrolling by invitation |
NCT03345654 -
Individually-guided Hearing Aid Fitting
|
||
Completed |
NCT06016335 -
MRI-based Synthetic CT Images of the Head and Neck
|
N/A | |
Completed |
NCT05165121 -
Comparison of Hearing Aid Fitting Outcomes Between Self-fit and Professional Fit for MDHearing Smart Hearing Aids
|
N/A | |
Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
Completed |
NCT04622059 -
AUditive Direct In-utero Observation (AUDIO): Prenatal Testing of Congenital Hypoacusis
|
N/A | |
Terminated |
NCT02294812 -
Effects of Cognitive Training on Speech Perception
|
N/A | |
Recruiting |
NCT02558478 -
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing
|
N/A | |
Withdrawn |
NCT02740322 -
Validating the Hum Test
|
N/A | |
Completed |
NCT01963104 -
Community-Based Kiosks for Hearing Screening and Education
|
N/A | |
Completed |
NCT01892007 -
Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users
|
N/A | |
Completed |
NCT01857661 -
The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial
|
N/A | |
Withdrawn |
NCT01223638 -
The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism
|
N/A |